Filing Flows

Filing Flows › Penumbra (PEN) › Next earnings date

Penumbra (PEN) earnings: missed the estimate

Penumbra (PEN) reported on Oct 29, 2026 and missed the EPS estimate: $1.20 against $1.21 (-0.3%). Revenue was $410M for Q3 2026, +16% year over year. It beat the EPS estimate in 40% of the quarters on record.

Last result−0.3% vs estimate
Beat rate40%

The last report

Penumbra reported revenue of $410M for the third quarter 2026 (+16% Y/Y), net earnings $42.3M: Thrombectomy $279M, Embolization and Access $131M. How it makes money → · Every quarter →

Penumbra: EPS against the estimate, last 5 reportsPenumbra: EPS against the estimate, last 5 reportsEstimateReported$0.92$0.97Nov 25$1.11$1.18Feb 26$1.06$1.01May 26$1.18$1.01Jul 26$1.21$1.20Oct 26
Latest (Oct 26): Estimate $1.21, Reported $1.20.
PEN: the stock's move on each reportPEN: the stock's move on each reportJul 30, 2026+0.3%May 6, 2026+0.2%Feb 25, 2026+0.7%Nov 5, 2025+12.6%

Penumbra's latest quarter

Penumbra, Q3 2026: revenue $410M (+16% year over year), operating margin 12.4%, net earnings $42.3M, operating cash flow $41.5M. The chart follows the revenue to costs, profit and cash.

Questions

Did Penumbra beat earnings?

Penumbra (PEN) reported on Oct 29, 2026 and missed the EPS estimate: $1.20 against $1.21 (-0.3%).

When does PEN report earnings?

The next date is not set yet.

Does Penumbra usually beat earnings?

It beat the consensus EPS estimate in 40% of the quarters on record.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.